Established care
Reduce risk and improve function
Smoking cessation, individualized inhalers, vaccination, pulmonary rehabilitation, oxygen for qualifying hypoxemia, and selected procedures remain the foundation of your care.
Breathe easier, with oversight
Stem cell therapy for COPD in Istanbul, Turkey
A respiratory-led program pairing GOLD-standard COPD management with cell-based support, physician monitoring, and transparent Istanbul pricing.
Conceptual biological visualization
Evidence status
What the evidence can support now
What we add
Immune and tissue support
Cell-based protocols are added for eligible patients, studied for feasibility, inflammatory signals, and exercise capacity.
What we won't promise
Rebuilt alveoli or restored FEV1
We won't promise lung regeneration or reduced oxygen dependence. We're clear about current evidence so you can make an informed decision.
A direct answer
The short answer
Our COPD program layers cell-based research protocols on top of your inhalers, pulmonary rehabilitation, oxygen therapy, and smoking-cessation support — it never replaces them. The main placebo-controlled MSC trial to date confirmed safety without a significant lung-function benefit, so we're honest about where the evidence stands while continuing to monitor emerging research. Results vary between patients and stem cell therapy is not a guaranteed cure.
Start with the phenotype
Your COPD phenotype shapes the plan
A COPD label alone isn't enough to define your risk, travel fitness, or a meaningful goal — we look deeper.
What your COPD care already includes
We build your regenerative plan on top of proven COPD management, never instead of it.
- Confirm persistent airflow obstruction with good-quality spirometry
- Stop smoking and reduce occupational or environmental exposure
- Use long-acting bronchodilators and selected anti-inflammatory treatment by phenotype
- Vaccination, pulmonary rehabilitation, nutrition, and exacerbation planning
- Oxygen for qualifying chronic hypoxemia and selected surgical or transplant referral
- 01
Emphysema burden
CT pattern, gas exchange, hyperinflation, and alveolar surface loss shape your clinical picture.
- 02
Chronic bronchitis
Mucus, airway inflammation, and exacerbation pattern can dominate your symptoms.
- 03
Exacerbation history
Recent hospitalizations, steroid or antibiotic courses, and infection risk matter for timing your visit.
- 04
Comorbidity
Pulmonary hypertension, heart disease, frailty, anxiety, and sleep-disordered breathing shape your safety and goals.
Product and route matter
We name the exact product and route
IV cells, nebulized products, and preclinical lung progenitors are different approaches — we tell you which one is in your protocol.
- 01
Intravenous MSCs
The best-studied human trials used specific IV stromal-cell products.
Evidence boundaryWe track feasibility and biomarker findings honestly against breathing and survival outcomes.
- 02
Nebulized products
Inhaled cells, secretome, or vesicles are offered by some clinics.
Evidence boundaryEvidence, lung deposition, and dosing differ from IV studies — we're upfront about the gap.
- 03
Autologous cell preparations
Bone marrow or adipose products differ in composition and processing.
Evidence boundaryWe don't transfer results from one preparation to another.
- 04
Lung progenitor research
Lineage-specific approaches target airway or alveolar biology.
Evidence boundaryDistinct from generic commercial MSC infusion, and not yet offered clinically.
Indexed evidence ledger
The controlled evidence, front and center
A biomarker shift is interesting, but we only count what changes how a patient breathes, functions, or stays out of hospital.
01 Placebo-controlled MSC trial
Open study- Product
- Four IV infusions of a defined allogeneic MSC product
- Study design
- Randomized, double-blind, placebo-controlled, 62 participants
- Finding
- Supported short-term feasibility and safety monitoring.
- Limitation
- No significant difference in pulmonary function, quality of life, or exacerbations; CRP findings were exploratory.
02 COPD clinical research review
Open study- Product
- Multiple cell sources and protocols
- Study design
- Review of registered and published studies
- Finding
- Mapped a fast-growing, early-stage research field.
- Limitation
- Different sources, doses, routes, and endpoints mean no single efficacy conclusion yet.
Measure what changes
What we track as meaningful progress
We set your outcome plan before travel and interpret every result alongside your standard COPD care.
- 01
Exacerbations
Steroid or antibiotic courses, emergency visits, admissions, and time to next exacerbation.
- 02
Lung function
FEV1, FVC, diffusion capacity, and hyperinflation when clinically relevant.
- 03
Exercise and oxygen
Six-minute walk, exertional saturation, oxygen requirement, and rehabilitation progress.
- 04
Patient experience
Validated dyspnea and quality-of-life instruments, not testimonial language alone.
Clinical review before travel
Your travel and respiratory review
Your evaluation confirms clinical stability and flight safety, not just eligibility for cell therapy.
Records to send
- Recent post-bronchodilator spirometry and full PFTs if available
- Chest CT or radiology reports, oxygen and saturation data
- Exacerbations, admissions, antibiotics, steroids, and ventilation history
- Inhaler list, technique, smoking status, and pulmonary rehabilitation
- Heart disease, pulmonary hypertension, sleep, and flight-oxygen assessment
Reasons to pause
- Current exacerbation, fever, or respiratory infection
- Unstable oxygen need, recent hospitalization, or decompensated heart disease
- Unresolved flight-safety or pulmonary-hypertension concern
- Any proposal to stop inhalers, oxygen, or rehabilitation
Transparent planning
COPD stem cell therapy cost in Istanbul, Turkey
Your written estimate names the product, route, respiratory testing, hospital monitoring, oxygen support, and follow-up — never a generic lung package.
For context, our general 2026 MSC planning range is $7,000-$18,000. Your COPD-specific quote is itemized after your respiratory evaluation.
- Pulmonary and cardiac fitness testing
- Exact cell or acellular product and release documentation
- IV, inhaled, or other route with hospital requirements
- Oxygen, monitoring, observation, and follow-up coordination
Questions patients ask us
- 01
How much does COPD stem cell therapy cost in Istanbul?
- 02
Which controlled trial matches this exact product and route?
- 03
How many days will I need to stay for evaluation and treatment?
- 04
How will the team coordinate inhalers, oxygen, rehabilitation, and emergency care?
FAQ
Questions about copd
Cell-based protocols are studied for feasibility and inflammatory signals in COPD, and we offer them as an addition to your inhalers, rehabilitation, and oxygen therapy, not a replacement. Results vary between patients and stem cell therapy is not a guaranteed cure.
Request Medical Evaluation
Begin a personalized treatment conversation with our medical team.
Share your case in confidence. Our international coordinators review every enquiry and respond within 24 hours, in your language.